(2021). Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report. Reactions Weekly.
Style de citation Chicago"Empagliflozin: Euglycemic and Hyperglycaemic Diabetic Ketoacidosis: Case Report." Reactions Weekly 2021.
Style de citation MLA"Empagliflozin: Euglycemic and Hyperglycaemic Diabetic Ketoacidosis: Case Report." Reactions Weekly 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.